Stock Scorecard
Stock Summary for Insulet Corporation (PODD) - $313.45 as of 10/8/2025 4:31:16 PM EST
Total Score
9 out of 30
Safety Score
57 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PODD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PODD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PODD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PODD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for PODD (57 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for PODD
Financial Details for PODD
Company Overview |
|
|---|---|
| Ticker | PODD |
| Company Name | Insulet Corporation |
| Country | USA |
| Description | Insulet Corporation (PODD) specializes in the development and manufacturing of innovative insulin delivery systems for individuals with insulin-dependent diabetes, aimed at enhancing patient quality of life and managing health outcomes. Headquartered in Acton, Massachusetts, Insulet is best known for its Omnipod® Insulin Management System, which offers a tubeless, wearable pump solution that promotes greater flexibility and ease of use for patients. With a strong commitment to improving diabetes management, the company continues to advance its technology portfolio and expand its global reach, positioning itself as a leader in the diabetes care market. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/6/2025 |
Stock Price History |
|
| Last Day Price | 313.45 |
| Price 4 Years Ago | 266.07 |
| Last Day Price Updated | 10/8/2025 4:31:16 PM EST |
| Last Day Volume | 479,941 |
| Average Daily Volume | 639,282 |
| 52-Week High | 353.50 |
| 52-Week Low | 225.37 |
| Last Price to 52 Week Low | 39.08% |
Valuation Measures |
|
| Trailing PE | 95.03 |
| Industry PE | 44.24 |
| Sector PE | 41.70 |
| 5-Year Average PE | 119.83 |
| Free Cash Flow Ratio | 22.21 |
| Industry Free Cash Flow Ratio | 37.96 |
| Sector Free Cash Flow Ratio | 30.25 |
| Current Ratio Most Recent Quarter | 2.23 |
| Total Cash Per Share | 14.11 |
| Book Value Per Share Most Recent Quarter | 20.78 |
| Price to Book Ratio | 15.03 |
| Industry Price to Book Ratio | 3.99 |
| Sector Price to Book Ratio | 32.02 |
| Price to Sales Ratio Twelve Trailing Months | 9.39 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.50 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.22 |
| Analyst Buy Ratings | 16 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 70,393,000 |
| Market Capitalization | 22,064,685,850 |
| Institutional Ownership | 101.82% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.68% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -87.70% |
| Annual Earnings Growth | 102.76% |
| Reported EPS 12 Trailing Months | 3.28 |
| Reported EPS Past Year | 2.19 |
| Reported EPS Prior Year | 3.33 |
| Net Income Twelve Trailing Months | 236,100,000 |
| Net Income Past Year | 418,300,000 |
| Net Income Prior Year | 206,300,000 |
| Quarterly Revenue Growth YOY | 32.90% |
| 5-Year Revenue Growth | 22.92% |
| Operating Margin Twelve Trailing Months | 18.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 992,900,000 |
| Total Cash Past Year | 953,400,000 |
| Total Cash Prior Year | 650,700,000 |
| Net Cash Position Most Recent Quarter | 53,900,000 |
| Net Cash Position Past Year | -342,700,000 |
| Long Term Debt Past Year | 1,296,100,000 |
| Long Term Debt Prior Year | 1,366,400,000 |
| Total Debt Most Recent Quarter | 939,000,000 |
| Equity to Debt Ratio Past Year | 0.48 |
| Equity to Debt Ratio Most Recent Quarter | 0.61 |
| Total Stockholder Equity Past Year | 1,211,600,000 |
| Total Stockholder Equity Prior Year | 732,700,000 |
| Total Stockholder Equity Most Recent Quarter | 1,462,900,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 388,300,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 5.52 |
| Free Cash Flow Past Year | 305,400,000 |
| Free Cash Flow Prior Year | 70,100,000 |
Options |
|
| Put/Call Ratio | 4.80 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.40 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 10/7/2025 7:24:23 AM EST |